Company intelligence / Profile preview

Bright Future Pharmaceutical Laboratories

Yuen Long, Hong Kong SAR Chinabrightfuture.com.hk ↗

Ownership: Private
Employees: ~7000
Development stage: Other

Overview

Bright Future Pharmaceutical Laboratories is a leading Hong Kong-based pharmaceutical manufacturer specializing in affordable generic medicines. The company has over four approved combination drugs in China targeting coughs and infectious diseases. It operates globally with subsidiaries/plants in Mainland China, USA, Germany; its portfolio includes more than 160 generic medicines and health supplements. Its pipeline focuses on dermatology, orthopedics, respiratory disease among others.

Therapeutic areas: PulmonologyInfectious Diseases
Modalities: Small moleculeProteinHerbal medicineHealth supplementSkincare product
Industry: Biotech

Beyond the preview

Go deeper on Bright Future Pharmaceutical Laboratories.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bright Future Pharmaceutical Laboratories.

Explore the full profile